Jeffrey Rathmell to Drug Synergism
This is a "connection" page, showing publications Jeffrey Rathmell has written about Drug Synergism.
Connection Strength
0.257
-
Targeting In Vivo Metabolic Vulnerabilities of Th2 and Th17 Cells Reduces Airway Inflammation. J Immunol. 2021 03 15; 206(6):1127-1139.
Score: 0.171
-
Multiplatform computational analysis of mast cells in adrenocortical carcinoma tumor microenvironment. Surgery. 2022 01; 171(1):111-118.
Score: 0.044
-
BET Inhibition Enhances the Antileukemic Activity of Low-dose Venetoclax in Acute Myeloid Leukemia. Clin Cancer Res. 2021 01 15; 27(2):598-607.
Score: 0.042